Covalon Technologies Profile

CAD 0.34  3.91%

Covalon Technologies Summary

Covalon Technologies Ltd (COV) is traded on TSX Venture Exchange in Canada. It is located in 1660 Tech Avenue and employs 8 people. The company currently falls under 'Small-Cap' category with current market capitalization of 197.29 M. Covalon Technologies Ltd classifies itself under Healthcare sector and is part of Biotechnology industry. This company has 21.68 M outstanding shares of which 5.79 K shares are currently shorted by private and institutional investors with about 0.16 days to cover all short positions. COVALON TECHNOLOG has accumulated about 1.72 M in cash with (807.02 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.08.
Check Covalon Technologies Probability Of Bankruptcy

Ownership Allocation (%)

Covalon Technologies Target Price Odds Analysis

Odds Below 8.35HorizonTargetOdds Above 8.35
56.37%30 days 8.35 43.48%
Based on normal probability distribution, the odds of Covalon Technologies to move above current price in 30 days from now is about 43.48% (This Covalon Technologies Ltd probability density function shows the probability of Covalon Technologies Stock to fall within a particular range of prices over 30 days) .

Covalon Technologies Risk Profiles

Covalon Technologies Key Fundamentals

Covalon Technologies Against Markets

Covalon Technologies Current Ratings

Covalon Technologies Ltd 30 Days Performance Scores

Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
Equity ratings for Covalon Technologies Ltd are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Covalon Technologies Ltd. researches, develops, manufactures, markets, and licenses medical technologies and products worldwide. The company offers its technologies, products, and services to various health care providers, such as hospitals, wound care centers, burn centers, extendedalternate care facilities, acute care facilities, home health care agencies, and physicians offices. Covalon Technologies operates under Biotechnology classification in Canada and traded on TSX Venture Exchange. more
NameCovalon Technologies Ltd
CEO and President and DirectorBrian PedlarView All
Macroaxis Advice
InstrumentCanada Stock View All
Business Address1660 Tech Avenue
ExchangeTSX Venture Exchange
Phone905 568 8400
CurrencyCAD - Canadian Dollar
Next Fiscal Year EndSeptember 30, 2019
Most Recent QuarterJune 30, 2018
Last Fiscal Year EndSeptember 30, 2017
Date Short InterestSeptember 4, 2018

Covalon Technologies Directors

Covalon Technologies Corporate Directors

Elinor Caplan Director
Murray Miller Independent Director
John Hands Sr. Director of Global Marketing
Check also Trending Equities. Please also try Portfolio Reporting module to create custom reports across your portfolios and generate quick suggestion pitch.